The candidate will join the ST3 DAS Oncology Discovery group to perform new target validation and support early stage small and large molecule therapeutic program programs. The scientist will work independently to perform assigned experiments, interpret complex data, rework experiments based on interpretations, and propose next steps. Troubleshooting skills are essential. The scientist will contribute to the preparation and submission of technical reports, prepare clear and concise summaries of their data and present to the project team and senior colleagues. The scientist will work well in a collaborative environment, be organized, and demonstrate urgency and be sensitive to timelines. The scientist will be proficient in multiple cell biology assays that could include cell culture, transfection/infection, siRNA/shRNA based knockdown studies, multi-color flow cytometry, cell proliferation and cytotoxicity (using Incucyte), immune cell based cell killing assays, Western blotting, capillary protein electrophoresis, immunoprecipitation.
Education: Typically will have an M.S. with 2 or more years of experience or a B.S./B.A. with 2-5 or more years of experience, or the equivalent training/experience. Strong cell culture, cell biology and assay development skills are required. A good background in cancer biology is desirable. Prior biotech/pharma experience is preferred.